Stay updated on Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page’s software/version revision indicator was updated from v3.5.2 to v3.5.3, reflecting a general release-level change rather than an update to the trial history or study details.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedThe latest version adds a 'Study Status' entry to the history (revision v3.4.3, dated 2026-03-11); the prior revision (v3.4.2, 2025-12-24) is removed.SummaryDifference0.3%

- Check74 days agoChange DetectedThe page history shows a new site revision (v3.4.2) was added, and an old funding-notice and a previous revision (v3.4.1) were removed.SummaryDifference0.5%

- Check82 days agoChange DetectedA site-wide notice about a government funding lapse was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.